Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Furthermore, we detected significant inverse associations of Afamin with complement C3, serum albumin, hemoglobin, and 25(OH)-Vitamin D3 levels (Table 3).

Source: Correlation of urine/plasma Afamin with different clinical and laboratory manifestations in LN patients. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

All participants were recruited from Nanjing Drum Tower Hospital.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Urine Afamin as a biomarker of lupus nephritis

Study design awaiting verification · Frontiers in Immunology · 2025

Original publication title

Urine Afamin as a biomarker of lupus nephritis

Shiyu Lin; Mengru Du; Jie Wang; Peng Lai; Genhong Yao; Weiwei Chen; Xue Xu; Lingyun Sun

Copyright © 2025 Lin, Du, Wang, Lai, Yao, Chen, Xu and Sun.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The uAfamin level serves as a biomarker for LN, aiding in monitoring disease progression and suggesting a new avenue for personalized treatment strategies.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

The association between various biomarkers and the risk of lupus nephritis (LN) has been extensively investigated. However, a dearth of readily available, specific, and sensitive diagnostic biomarkers for LN remains. This study aimed to examine the levels of Afamin in the urine and plasma of patients with systemic lupus erythematosus (SLE) and to evaluate its potential utility for diagnosing LN.

Source: Objective

Abstract: What methods does the paper describe?

This study enrolled 31 LN: SLE patients, 31 non-LN: SLE patients, and 27 healthy controls (HC). First, tandem mass tag (TMT): based proteomic screening of urine and plasma (n = 15 per group) identified Afamin as a significantly upregulated protein in LN. Subsequently, ELISA validation confirmed that both uAfamin and pAfamin levels were markedly higher in the LN group. The diagnostic performance of uAfamin for active LN was further evaluated using receiver operating characteristic (ROC) curve analysis.

Source: Methods

Abstract: Results

Levels of both urinary and plasma Afamin were significantly elevated in patients with LN: SLE compared to those with non-LN: SLE. Moreover, uAfamin and pAfamin levels demonstrated robust correlations with multiple clinical indicators of disease activity, including 24h urinary total protein (24hUTP), creatinine, urea, hematuria, pyuria, SLEDAI, and renal SLEDAI. Multivariable linear regression analysis established uAfamin as an independent determinant of renal SLEDAI scores. Consistent with this, ROC curve analysis confirmed that uAfamin possesses a strong capacity to diagnose LN.

Source: Results

Abstract: Conclusion

The uAfamin level serves as a biomarker for LN, aiding in monitoring disease progression and suggesting a new avenue for personalized treatment strategies.

Source: Conclusion
Authors’ abstract

Objective

The association between various biomarkers and the risk of lupus nephritis (LN) has been extensively investigated. However, a dearth of readily available, specific, and sensitive diagnostic biomarkers for LN remains. This study aimed to examine the levels of Afamin in the urine and plasma of patients with systemic lupus erythematosus (SLE) and to evaluate its potential utility for diagnosing LN.

Methods

This study enrolled 31 LN: SLE patients, 31 non-LN: SLE patients, and 27 healthy controls (HC). First, tandem mass tag (TMT): based proteomic screening of urine and plasma (n = 15 per group) identified Afamin as a significantly upregulated protein in LN. Subsequently, ELISA validation confirmed that both uAfamin and pAfamin levels were markedly higher in the LN group. The diagnostic performance of uAfamin for active LN was further evaluated using receiver operating characteristic (ROC) curve analysis.

Results

Levels of both urinary and plasma Afamin were significantly elevated in patients with LN: SLE compared to those with non-LN: SLE. Moreover, uAfamin and pAfamin levels demonstrated robust correlations with multiple clinical indicators of disease activity, including 24h urinary total protein (24hUTP), creatinine, urea, hematuria, pyuria, SLEDAI, and renal SLEDAI. Multivariable linear regression analysis established uAfamin as an independent determinant of renal SLEDAI scores. Consistent with this, ROC curve analysis confirmed that uAfamin possesses a strong capacity to diagnose LN.

Conclusion

The uAfamin level serves as a biomarker for LN, aiding in monitoring disease progression and suggesting a new avenue for personalized treatment strategies.

Publication and source details

Original title: Urine Afamin as a biomarker of lupus nephritis

Shiyu Lin; Mengru Du; Jie Wang; Peng Lai; Genhong Yao; Weiwei Chen; Xue Xu; Lingyun Sun

Frontiers in Immunology · 2025

* Correspondence: Xue Xu, iamxuxue@163.com; Genhong Yao, yaogenhong@nju.edu.cn; Weiwei Chen, chenweiweinj@163.com
†

These authors have contributed equally to this work

Copyright © 2025 Lin, Du, Wang, Lai, Yao, Chen, Xu and Sun.2025Lin, Du, Wang, Lai, Yao, Chen, Xu and Sunhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declare financial support was received for the research and/or publication of this article. The National Science Foundation of China (NSFC) (grant no. 81970062 to GY) Jiangsu Innovative and Entrepreneurial Talent Program (JSSCBS20211493) The Clinical Research Special Foundation of Nanjing Drum Tower Hospital(No. 2024-LCYJ-PY-04).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:31:40.718929+00:00

DOI: 10.3389/fimmu.2025.1696288 · PMC12698515